Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Lipidology|July 9, 2008
HDL metabolism in context: looking on the bright sideGerald F Watts, P Hugh R Barrett, Dick C Chan
Clinical Science (London, England : 1979)|July 1, 2004
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methodsDick C Chan, P Hugh R Barrett, Gerald F Watts
European Journal of Endocrinology|May 14, 2017
Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis developmentVita Birzniece, P Hugh R Barrett, Ken K Y Ho
The Clinical Biochemist. Reviews|June 3, 2008
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studiesDick C Chan, P Hugh R Barrett, Gerald F Watts
Current Opinion in Lipidology|November 3, 2016
Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolismDick C Chan, P Hugh R Barrett, Gerald F Watts
International Journal of Cardiology|August 3, 2013
The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapiesEsther M M Ooi, P Hugh R Barrett, Gerald F Watts
Endocrinology|February 25, 2016
Modeling the Male Reproductive Endocrine Axis: Potential Role for a Delay Mechanism in the Inhibitory Action of Gonadal Steroids on GnRH Pulse FrequencyTeuku R Ferasyi, P Hugh R Barrett, Dominique Blache, et al.
Current Opinion in Lipidology|May 19, 2012
Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspectsJing Pang, Dick C Chan, P Hugh R Barrett, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2006
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjectsRegina E Dinkel, P Hugh R Barrett, Thomas Demant, et al.
Circulation|December 4, 2002
Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbitShirya Rashid, Kristine D Uffelman, P Hugh R Barrett, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Lipidology|July 9, 2008
HDL metabolism in context: looking on the bright sideGerald F Watts, P Hugh R Barrett, Dick C Chan
Clinical Science (London, England : 1979)|July 1, 2004
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methodsDick C Chan, P Hugh R Barrett, Gerald F Watts
European Journal of Endocrinology|May 14, 2017
Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis developmentVita Birzniece, P Hugh R Barrett, Ken K Y Ho
The Clinical Biochemist. Reviews|June 3, 2008
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studiesDick C Chan, P Hugh R Barrett, Gerald F Watts
Current Opinion in Lipidology|November 3, 2016
Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolismDick C Chan, P Hugh R Barrett, Gerald F Watts
International Journal of Cardiology|August 3, 2013
The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapiesEsther M M Ooi, P Hugh R Barrett, Gerald F Watts
Endocrinology|February 25, 2016
Modeling the Male Reproductive Endocrine Axis: Potential Role for a Delay Mechanism in the Inhibitory Action of Gonadal Steroids on GnRH Pulse FrequencyTeuku R Ferasyi, P Hugh R Barrett, Dominique Blache, et al.
Current Opinion in Lipidology|May 19, 2012
Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspectsJing Pang, Dick C Chan, P Hugh R Barrett, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 4, 2006
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjectsRegina E Dinkel, P Hugh R Barrett, Thomas Demant, et al.
Circulation|December 4, 2002
Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbitShirya Rashid, Kristine D Uffelman, P Hugh R Barrett, et al.
Pageof 15